May 28, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Patients with systemic autoimmune rheumatic disease demonstrate an increased persistence of SARS-CoV-2 antigen positivity up to 6 months after COVID-19 infection, according to data published in Arthritis & Rheumatology.“Longer duration of SARS-CoV-2 antigen persistence in the blood has been associated with various outcomes including higher risk of post-acute sequelae of COVID-19,”
May 28, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Yale study links some long COVID patients to autoimmune responses

Serology Affects Transition From Arthralgia to Full-Blown Rheumatoid Arthritis

Understanding the potential of CAR-T therapy in autoimmune disease treatment

Polimialgia reumatica con necessità di cortisone ad alte dosi (31/05/2026) | Forum Malattie reumatiche e autoimmuni | Il Medico Risponde - Corriere.it

CHICAGO — Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced…

A dual-target CD19/BCMA chimeric antigen receptor T-cell therapy yielded “profound, sustained” remission in 11 patients with…

ORLANDO — Following hospitalization for an exacerbation of interstitial lung disease related to systemic autoimmune rheumatic…

Depression and inflammation may be intimately linked through connections between the brain and the immune system, according a…

Breaking news, emerging data, features and Q&As at the intersection of COVID-19 and rheumatology.

There were three turning points in my early training that led me to rheumatology. The first was in medical school during didactic…